Siyuan Yan
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Loss of branched-chain amino acid (BCAA) metabolism mediated by IGF2BP1-LPAL2-YBX1 interaction promotes malignancy in gallbladder cancer.
Journal: Cancer letters
Published: August 05, 2025
Macrophage-rich niches regulate T cell dynamics at the liver invasive margin during gallbladder cancer progression.
Journal: The Journal of clinical investigation
Published: March 24, 2025
Super-Enhancer Reprograming Driven by SOX9 and TCF7L2 Represents Transcription-Targeted Therapeutic Vulnerability for Treating Gallbladder Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 11, 2024
Targeting Super-Enhancer-Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance.
Journal: Cancer research
Published: October 23, 2023
Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis.
Journal: Journal of translational medicine
Published: October 03, 2023
Rationality of irrationality: preference catering or shaping?
Journal: Journal of medical ethics
Published: June 14, 2023
Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer.
Journal: Journal of hepatology
Published: October 23, 2020
Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
Journal: Cancer science
Published: August 24, 2019
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression.
Journal: Cell research
Published: April 14, 2019
Last Updated: 09/26/2026